Korean Journal Of Physiology & Pharmacology SCIE

国际简称：KOREAN J PHYSIOL PHA 参考译名：韩国生理学与药理学杂志

主要研究方向：PHARMACOLOGY & PHARMACY-PHYSIOLOGY 非预警期刊审稿周期：较慢,6-12周

《韩国生理学与药理学杂志》(Korean Journal Of Physiology & Pharmacology)是一本由Korean Physiological Soc. and Korean Soc. of Pharmacology出版的以PHARMACOLOGY & PHARMACY-PHYSIOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q3 JCR分区
51 年发文量
1.6 IF影响因子
开放是否OA
23 H-index
1997 创刊年份
Bimonthly 出版周期
English 出版语言

The Korean Journal of Physiology & Pharmacology (Korean J. Physiol. Pharmacol., KJPP) is the official journal of both the Korean Physiological Society (KPS) and the Korean Society of Pharmacology (KSP). The journal launched in 1997 and is published bi-monthly in English. KJPP publishes original, peer-reviewed, scientific research-based articles that report successful advances in physiology and pharmacology. KJPP welcomes the submission of all original research articles in the field of physiology and pharmacology, especially the new and innovative findings. The scope of researches includes the action mechanism, pharmacological effect, utilization, and interaction of chemicals with biological system as well as the development of new drug targets. Theoretical articles that use computational models for further understanding of the physiological or pharmacological processes are also welcomed. Investigative translational research articles on human disease with an emphasis on physiology or pharmacology are also invited. KJPP does not publish work on the actions of crude biological extracts of either unknown chemical composition (e.g. unpurified and unvalidated) or unknown concentration. Reviews are normally commissioned, but consideration will be given to unsolicited contributions. All papers accepted for publication in KJPP will appear simultaneously in the printed Journal and online.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Korean Journal Of Physiology & Pharmacology期刊信息

ISSN：1226-4512
出版语言：English
是否OA：开放
E-ISSN：2093-3827
出版地区：Korea
是否预警：否
出版商：Korean Physiological Soc. and Korean Soc. of Pharmacology
出版周期：Bimonthly
创刊时间：1997
开源占比：1
Gold OA文章占比：100.00%
OA被引用占比：0.3623...
出版国人文章占比：0.2
出版撤稿占比：0
研究类文章占比：94.12%

Korean Journal Of Physiology & Pharmacology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

3.2

0.405

0.447

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q3	202 / 313	35%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Physiology	Q3	138 / 193	28%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Korean Journal Of Physiology & Pharmacology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学	4区 4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学	4区 4区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学	4区 4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学	4区 4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学	4区 4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学	4区 4区

Korean Journal Of Physiology & Pharmacology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q3	259 / 354	27%
学科：PHYSIOLOGY	SCIE	Q4	68 / 85	20.6%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q3	218 / 354	38.56%
学科：PHYSIOLOGY	SCIE	Q4	66 / 85	22.94%

Korean Journal Of Physiology & Pharmacology历年数据统计

影响因子

中科院分区

Korean Journal Of Physiology & Pharmacology中国学者发文选摘

1、SKF96365 impedes spinal glutamatergic transmission-mediated neuropathic allodynia
Author: Wang, Qiru; Zhang, Yang; Du, Qiong; Zhao, Xinjie; Wang, Wei; Zhai, Qing; Xiang, Ming

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 39-48. DOI: 10.4196/kjpp.2023.27.1.39
2、GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways
Author: Wang, Gang; Ouyang, Baisha; Jing, Fang; Dai, Xiaoyan

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 21-29. DOI: 10.4196/kjpp.2023.27.1.21
3、Hydrogen sulfide alleviates hypothyroidism-induced myocardial fibrosis in rats through stimulating autophagy and inhibiting TGF-(31/Smad2 pathway
Author: Song, Xiong; Nie, Liangui; Long, Junrong; Zhao, Junxiong; Liu, Xing; Wang, Liuyang; Liu, Da; Wang, Sen; Liu, Shengquan; Yang, Jun

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 1-8. DOI: 10.4196/kjpp.2023.27.1.1
4、Exosome-mediated lnc-ABCA12-3 promotes proliferation and glycolysis but inhibits apoptosis by regulating the tolllike receptor 4/nuclear factor kappa-B signaling pathway in esophageal squamous cell carcinoma
Author: Ma, Junliang; Luo, Yijun; Liu, Yingjie; Chen, Cheng; Chen, Anping; Liang, Lubiao; Wang, Wenxiang; Song, Yongxiang

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 61-73. DOI: 10.4196/kjpp.2023.27.1.61
5、Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-?
Author: Li, Hongming; Qiu, Yumei; Xie, Mengdie; Ouyang, Changsheng; Ding, Xiaoyun; Zhang, Hao; Dong, Wei; Xiong, Yinhua; Tang, Xilan

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 75-84. DOI: 10.4196/kjpp.2023.27.1.75
6、Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice
Author: Zhu, Qian; Zhou, Qu; Luo, Xiao-li; Zhang, Xu-jie; Li, San-yu

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 3, pp. 221-230. DOI: 10.4196/kjpp.2023.27.3.221
7、Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression
Author: Zheng, Wan; Li, Tianfa; Wei, Junping; Yan, Yani; Yang, Shanshan

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 3, pp. 209-220. DOI: 10.4196/kjpp.2023.27.3.209
8、LINC00562 drives gastric cancer development by regulating miR-4636-AP1S3 axis
Author: Xu, Lin; Liu, Daiting; Wang, Xun

Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 3, pp. 197-208. DOI: 10.4196/kjpp.2023.27.3.197